MET and ductal breast carcinoma in situ: Normal mammary fibroblasts engineered to secrete HGF have been reported to increase invasiveness of c-met expressing human ductal carcinoma in situ (DCIS) cells in vitro and promote the in vivo transition of nude mice DCIS cell xenografts to invasive carcinomas (Jedeszko et al, 2009).